查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594495

菸鹼醯胺市場：依形式、產量、等級、應用分類 - 2025-2030 年全球預測

Niacinamide Market by Form (Granular, Liquid, Powder), Production (Natural, Synthetic), Grade, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年菸鹼醯胺市值為7.1577億美元，預計到2024年將達到7.456億美元，複合年成長率為4.65%，預計到2030年將達到9.8411億美元。

菸鹼醯胺是維生素 B3 的一種，是一種多方面的成分，護膚功效而得到廣泛認可，並為化妝品和個人護理行業提供顯著的付加。它的需求源於其發炎、抗衰老和美白特性，吸引了尋求多功能護膚解決方案的消費者。菸鹼醯胺應用於針對痤瘡、色素沉著和皮膚保濕的乳霜、精華液和乳液中。由於其對神經和消化器官系統的有益作用，其最終用途範圍已從護膚擴展到食品和藥品。

主要市場統計
基準年[2023] 71577萬美元
預測年份 [2024] 7.456 億美元
預測年份 [2030] 98411萬美元
複合年成長率（%） 4.65%

市場成長的主要驅動力是消費者對護膚和健康意識的提高、對天然和多功能成分的需求不斷成長以及皮膚病患病率的上升。快速成長的美容和個人護理行業是由對有機和永續產品的強烈關注所推動的。此外，將菸鹼醯胺整合到不同的產品線中可以促進從高階品牌到大眾市場產品的多個切入點和用戶細分。

儘管前景廣闊，但市場成長面臨挑戰，例如化妝品配方的嚴格監管以及用戶潛在的皮膚敏感性問題。來自透明質酸和維生素 C 等替代成分的競爭壓力也帶來了限制。

為了利用市場機會，公司應專注於將菸鹼醯胺與補充成分結合的創新配方，以最佳化產品功效和消費者滿意度。投資於探索頭髮和指甲護理更廣泛應用的研究可能會開啟進一步的市場空間。強調產品採購和生產過程的透明度和永續性可以提高品牌信任度和吸引力，特別是在消費者環保意識增強的情況下。市場是充滿活力和競爭的，技術創新主要反映產品交付方法的進步和配方的改進。透過響應不斷變化的消費者偏好並利用護膚功效測試方面的技術進步，公司可以在這個充滿活力的市場空間中佔據獨特的地位。

市場動態：揭示快速發展的菸鹼醯胺市場的關鍵市場洞察

供需的動態相互作用正在改變菸鹼醯胺市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 消費者對含菸鹼醯胺食品或治療糖尿病、骨關節炎和高磷酸鹽血症的補充品的需求
    • 對含有菸鹼醯胺的護膚品的需求不斷成長
    • 增加菸鹼醯胺在飼料強化的使用
  • 市場限制因素
    • 原物料供應有限且價格波動
  • 市場機會
    • 廣泛的研究和開發工作，開發用於癌症治療的菸鹼醯胺治療方法
    • 對非處方藥 (OTC) 的偏好日益成長
  • 市場挑戰
    • 長期使用菸鹼醯胺相關的副作用和過敏反應

波特五力：駕馭菸鹼醯胺市場的策略工具

波特的五力框架是了解菸鹼醯胺市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解菸鹼醯胺市場的外部影響

外部宏觀環境因素在塑造菸鹼醯胺市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解菸鹼醯胺市場的競爭格局

對菸鹼醯胺市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣菸鹼醯胺市場供應商的績效評估

FPNV定位矩陣是評估菸鹼醯胺市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製您在菸鹼醯胺市場的成功之路

菸鹼醯胺市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 消費者對含菸鹼醯胺食品和治療糖尿病、骨關節炎和高磷酸鹽血症補充品的需求
      • 對含有菸鹼醯胺的護膚品的需求增加
      • 增加菸鹼醯胺在動物飼料強化的使用
    • 抑制因素
      • 原物料供應和價格波動的限制
    • 機會
      • 廣泛的研發工作開發用於癌症治療的菸鹼醯胺治療方法
      • 人們越來越偏好市售化妝品
    • 任務
      • 長期使用菸鹼醯胺相關的副作用和過敏反應
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章菸鹼醯胺市場：依形式

  • 顆粒狀
  • 液體
  • 粉末

第7章菸鹼醯胺市場創造者

  • 自然的
  • 合成

第8章菸鹼醯胺市場：依等級

  • 飼料級
  • 醫藥級

第9章菸鹼醯胺市場：依應用分類

  • 動物營養
  • 化妝品
  • 人類營養
  • 藥品

第10章美洲菸鹼醯胺市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太菸鹼醯胺市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲菸鹼醯胺市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AIE Pharmaceuticals, Inc.
  • Bio-Tech Pharmacal, Inc.
  • Evonik Industries AG
  • Fagron Inc.
  • Foodchem International Corporation
  • Gemini Pharmaceuticals
  • Glanbia PLC
  • Koninklijke DSM NV
  • Lasons India Pvt Ltd.
  • Lonza Group AG
  • Merck KGaA
  • NutraScience Labs
  • Spectrum Chemical Mfg. Corporation
  • Vertellus LLC
  • Western Drugs Ltd.
  • Yuki Gosei Kogyo Co., Ltd.
Product Code: MRR-9E01E2DC4AC3

The Niacinamide Market was valued at USD 715.77 million in 2023, expected to reach USD 745.60 million in 2024, and is projected to grow at a CAGR of 4.65%, to USD 984.11 million by 2030.

Niacinamide, a form of vitamin B3, is a multifaceted ingredient widely recognized for its skincare benefits, adding significant value to the cosmetics and personal care industries. Its necessity arises from its anti-inflammatory, anti-aging, and brightening properties, appealing to consumers seeking multifunctional skincare solutions. Niacinamide finds applications in creams, serums, and lotions targeting acne, hyperpigmentation, and skin hydration. The end-use scope extends beyond skincare, encompassing dietary supplements and pharmaceutical products due to its beneficial impacts on the nervous and digestive systems.

KEY MARKET STATISTICS
Base Year [2023] USD 715.77 million
Estimated Year [2024] USD 745.60 million
Forecast Year [2030] USD 984.11 million
CAGR (%) 4.65%

Market growth is primarily driven by increasing consumer awareness of skincare and wellness, escalating demand for natural and versatile ingredients, and the rising prevalence of skin disorders. The burgeoning beauty and personal care industry, with a strong inclination towards organic and sustainable products, catalyzes the market expansion. Furthermore, the integration of niacinamide in diverse product lines fosters multiple entry points and user segments, from premium brands to mass-market offerings.

Despite its promising outlook, market growth faces challenges, including stringent regulations surrounding cosmetic formulations and potential skin sensitivity issues among users. Competitive pressures from alternative ingredients, such as hyaluronic acid and vitamin C, also pose limitations.

To capitalize on market opportunities, companies should focus on innovative formulations that combine niacinamide with complementary ingredients, ensuring optimal product efficacy and consumer satisfaction. Investing in research that explores its broader applications in hair and nail care could unlock additional market spaces. Emphasizing transparency and sustainability in product sourcing and production processes can enhance brand trust and appeal, especially amid increasing consumer environmental consciousness. The market is dynamic and highly competitive, with innovation predominantly reflecting advancements in product delivery methods and enhanced formulations. By staying attuned to evolving consumer preferences and leveraging technological advancements in skincare efficacy testing, businesses can carve out a unique position in this vibrant market space.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Niacinamide Market

The Niacinamide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
    • Increasing demand for skin care products containing niacinamide
    • Growing use of niacinamide for animal feed fortification
  • Market Restraints
    • Limited availability and volatility of the prices of ingredients
  • Market Opportunities
    • Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
    • Growing preference for Over-the-counter (OTC) cosmeceuticals
  • Market Challenges
    • Adverse side effects and allergic reactions associated with the long-term use of niacinamide

Porter's Five Forces: A Strategic Tool for Navigating the Niacinamide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Niacinamide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Niacinamide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Niacinamide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Niacinamide Market

A detailed market share analysis in the Niacinamide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Niacinamide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Niacinamide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Niacinamide Market

A strategic analysis of the Niacinamide Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Niacinamide Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc., Bio-Tech Pharmacal, Inc., Evonik Industries AG, Fagron Inc., Foodchem International Corporation, Gemini Pharmaceuticals, Glanbia PLC, Koninklijke DSM N.V., Lasons India Pvt Ltd., Lonza Group AG, Merck KGaA, NutraScience Labs, Spectrum Chemical Mfg. Corporation, Vertellus LLC, Western Drugs Ltd., and Yuki Gosei Kogyo Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Niacinamide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Granular, Liquid, and Powder.
  • Based on Production, market is studied across Natural and Synthetic.
  • Based on Grade, market is studied across Feed Grade and Pharmaceutical Grade.
  • Based on Application, market is studied across Animal Nutrition, Cosmeceuticals, Human Nutrition, and Pharmaceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
      • 5.1.1.2. Increasing demand for skin care products containing niacinamide
      • 5.1.1.3. Growing use of niacinamide for animal feed fortification
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and volatility of the prices of ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
      • 5.1.3.2. Growing preference for Over-the-counter (OTC) cosmeceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse side effects and allergic reactions associated with the long-term use of niacinamide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Niacinamide Market, by Form

  • 6.1. Introduction
  • 6.2. Granular
  • 6.3. Liquid
  • 6.4. Powder

7. Niacinamide Market, by Production

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Niacinamide Market, by Grade

  • 8.1. Introduction
  • 8.2. Feed Grade
  • 8.3. Pharmaceutical Grade

9. Niacinamide Market, by Application

  • 9.1. Introduction
  • 9.2. Animal Nutrition
  • 9.3. Cosmeceuticals
  • 9.4. Human Nutrition
  • 9.5. Pharmaceuticals

10. Americas Niacinamide Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Niacinamide Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Niacinamide Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AIE Pharmaceuticals, Inc.
  • 2. Bio-Tech Pharmacal, Inc.
  • 3. Evonik Industries AG
  • 4. Fagron Inc.
  • 5. Foodchem International Corporation
  • 6. Gemini Pharmaceuticals
  • 7. Glanbia PLC
  • 8. Koninklijke DSM N.V.
  • 9. Lasons India Pvt Ltd.
  • 10. Lonza Group AG
  • 11. Merck KGaA
  • 12. NutraScience Labs
  • 13. Spectrum Chemical Mfg. Corporation
  • 14. Vertellus LLC
  • 15. Western Drugs Ltd.
  • 16. Yuki Gosei Kogyo Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. NIACINAMIDE MARKET RESEARCH PROCESS
  • FIGURE 2. NIACINAMIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NIACINAMIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY GRANULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY HUMAN NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023